The change of drug utilization in China's public healthcare institutions under the "4 + 7" centralized drug procurement policy: Evidence from a natural experiment in China.

Lu, Jiancheng; Long, Hongfei; Shen, Yuan; Wang, Jing; Geng, Xin; Yang, Ying; Mao, Zongfu; Li, Jinghua

Lu, Jiancheng; Long, Hongfei; Shen, Yuan; Wang, Jing; Geng, Xin; Yang, Ying; Mao, Zongfu; Li, Jinghua.

Afiliação

Lu J; School of Public Health, Jilin University, Changchun, China.
Long H; Department of Drug Information Management, Statistical Information Center, National Health Commission of the People's Republic of China, Beijing, China.
Shen Y; Dong Fureng Economic and Social Development School, Wuhan University, Wuhan, China.
Wang J; Global Health Institute, Wuhan University, Wuhan, China.
Geng X; Department of Drug Information Management, Statistical Information Center, National Health Commission of the People's Republic of China, Beijing, China.
Yang Y; Department of Drug Information Management, Statistical Information Center, National Health Commission of the People's Republic of China, Beijing, China.
Mao Z; School of Public Health, Wuhan University, Wuhan, China.
Li J; Global Health Institute, Wuhan University, Wuhan, China.

Front Pharmacol ; 13: 923209, 2022.

Article em En | MEDLINE | ID: mdl-36081942